About Myst Therapeutics
Myst Therapeutics is a Healthcare company based in Los Angeles (United States) founded in 2019, and was acquired by Turnstone Biologics in January 2021. Developer of cell therapy for treating cancer. Its chief executive, as recorded, is Timothy Langer. Its focus areas include Life Sciences, Cell Therapy, Adoptive Cell Therapy and T-Cell. Its competitors include Poseida Therapeutics, Juno Therapeutics and TScan Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Myst Therapeutics was founded in 2019 and is based in Los Angeles, United States. Operations focus on the biotechnology sector, specifically adoptive cell therapy for oncology. T cells sourced from tumors and peripheral blood are utilized to target a wide range of cancer mutations. Development efforts center on advancing this therapy through clinical and preclinical stages.
- Headquarters Los Angeles, United States
- Stage Acquired
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website myst-tx.com
- Social LinkedIn
- Acquired by Turnstone Biologics (Jan 2021)
- Investors
- Acquired byTurnstone Biologics
(Jan 2021)
Investors in Myst Therapeutics
Myst Therapeutics has secured backing from 1 investor. Prominent investors backing the company include XOMA Royalty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
XOMA Royalty is engaged in biotech royalty aggregation activities. | 2015 | turnstonebio.com | San Diego, United States |
Investor details for Myst Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Myst Therapeutics
1 people are tracked at Myst Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Timothy Langer | CEO | Leadership |
Complete people profiles for Myst Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Myst Therapeutics
2 dated milestones of Myst Therapeutics across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Myst Therapeutics is founded.
- Exit Acquired by Turnstone Biologics.
Competitors of Myst Therapeutics
Myst Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Poseida Therapeutics, Juno Therapeutics and TScan Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| junotherapeutics.com | 2013 | Seattle, United States | $316.67M | 520 | CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | |
| tscan.com | 1995 | Boston, United States | $158.3M | 154 | T cell-based treatments for immunological and oncological disorders are developed. |
Detailed competitors of Myst Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
3 companies that operate in the same segment as Myst Therapeutics (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Myst Therapeutics
Complete news archive for Myst Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Myst Therapeutics
Myst Therapeutics was founded in 2019.
Myst Therapeutics is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Timothy Langer is the CEO of Myst Therapeutics, as recorded in our data.
Myst Therapeutics was founded in 2019 and is based in Los Angeles, United States. Operations focus on the biotechnology sector, specifically adoptive cell therapy for oncology. T cells sourced from tumors and peripheral blood are utilized to target a wide range of cancer mutations. Development efforts center on advancing this therapy through clinical and preclinical stages.
Myst Therapeutics's top competitors include Juno Therapeutics, Poseida Therapeutics and TScan Therapeutics.
Myst Therapeutics has 1 investor. Key investors include XOMA Royalty.
Yes. Myst Therapeutics was acquired by Turnstone Biologics in January 2021.

